Related references
Note: Only part of the references are listed.Safety and Immunogenicity of Adenovirus-Vectored Near-Consensus HIV Type 1 Clade B gag Vaccines in Healthy Adults
Clayton D. Harro et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2009)
Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control
April L. Ferre et al.
BLOOD (2009)
Heterologous prime-boost vaccinations for poverty-related diseases: advantages and future prospects
Katarina Radosevic et al.
EXPERT REVIEW OF VACCINES (2009)
Protection and Polyfunctional T Cells Induced by Ag85B-TB10.4/IC31® against Mycobacterium tuberculosis Is Highly Dependent on the Antigen Dose
Claus Aagaard et al.
PLOS ONE (2009)
Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
Kathryn T. Whelan et al.
PLOS ONE (2009)
A Critical Role for CD8 T Cells in a Nonhuman Primate Model of Tuberculosis
Crystal Y. Chen et al.
PLOS PATHOGENS (2009)
Early T-cell responses in tuberculosis immunity
Gary M. Winslow et al.
IMMUNOLOGICAL REVIEWS (2008)
Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa
Tony Hawkridge et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Safety and Immunogenicity of the Candidate Tuberculosis Vaccine MVA85A in West Africa
Roger H. Brookes et al.
PLOS ONE (2008)
rBCG Induces Strong Antigen-Specific T Cell Responses in Rhesus Macaques in a Prime-Boost Setting with an Adenovirus 35 Tuberculosis Vaccine Vector
Isabelle Magalhaes et al.
PLOS ONE (2008)
A comparison of IFNγ detection methods used in tuberculosis vaccine trials
Natalie E. R. Beveridge et al.
TUBERCULOSIS (2008)
Adenovirus 5 and 35 vectors expressing Plasmodium falciparum circumsporozoite surface protein elicit potent antigen-specific cellular IFN-γ and antibody responses in mice
Joseph P. Shott et al.
VACCINE (2008)
Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover
Jorge R. Almeida et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon
Katarina Radosevic et al.
INFECTION AND IMMUNITY (2007)
Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis
Hans-Willi Mittruecker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
Patricia A. Darrah et al.
NATURE MEDICINE (2007)
Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors
Kimberly McCoy et al.
JOURNAL OF VIROLOGY (2007)
Priming with an adenovirus 35-circumsporozoite protein (CS) vaccine followed by RTS,S/AS01B boosting significantly improves immunogenicity to Plasmodium falciparum CS compared to that with either malaria vaccine alone
V. Ann Stewart et al.
INFECTION AND IMMUNITY (2007)
IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection
Masayuki Umemura et al.
JOURNAL OF IMMUNOLOGY (2007)
Tumor necrosis factor is critical to control tuberculosis infection
Muazzam Jacobs et al.
MICROBES AND INFECTION (2007)
Immunogenicity of heterologous recombinant adenovirus prime-boost vaccine regimens is enhanced by circumventing vector cross-reactivity
Anna R. Thorner et al.
JOURNAL OF VIROLOGY (2006)
Novel replication-incompetent adenoviral B-group vectors: high vector stability and yield in PER.C6 cells
M. Havenga et al.
JOURNAL OF GENERAL VIROLOGY (2006)
Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells
Matthew A. Williams et al.
NATURE (2006)
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells
Michael R. Betts et al.
BLOOD (2006)
Effect of BCG vaccination on childhood tuberculous meningitis and miliarytuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness
BB Trunz et al.
LANCET (2006)
Immunogenicity and protection of a recombinant human adenovirus serotype 35-based malaria vaccine against Plasmodium yoelii in mice
OJAE Ophorst et al.
INFECTION AND IMMUNITY (2006)
Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis
F Winau et al.
IMMUNITY (2006)
Advances in tuberculosis vaccine strategies
Yasir A. W. Skeiky et al.
NATURE REVIEWS MICROBIOLOGY (2006)
Recent advances in the development of adenovirus- and poxvirus-vectored tuberculosis vaccines
Z Xing et al.
CURRENT GENE THERAPY (2005)
Immunogenicity of heterologous prime-boost regimens involving recombinant adenovirus serotype 11 (Ad11) and Ad35 vaccine vectors in the presence of anti-Ad5 immunity
AAC Lemckert et al.
JOURNAL OF VIROLOGY (2005)
Novel application of a whole blood intracellular cytokine detection assay to quantitate specific T-cell frequency in field studies
WA Hanekom et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2004)
Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans
H McShane et al.
NATURE MEDICINE (2004)
Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector
S Kostense et al.
AIDS (2004)
Quantifying adenovirus-neutralizing antibodies by luciferase transgene detection: Addressing preexisting immunity to vaccine and gene therapy vectors
MC Sprangers et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Enhanced immunogenicity of CD4+ T-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis
H McShane et al.
INFECTION AND IMMUNITY (2001)
Share Paper
